HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Irina Chuckowree Selected Research

PI 540

7/2009Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Irina Chuckowree Research Topics

Disease

4Neoplasms (Cancer)
11/2011 - 03/2004
1Respiratory Syncytial Virus Infections
01/2021
1Werner Syndrome (Werner's Syndrome)
06/2015
1Glioblastoma (Glioblastoma Multiforme)
07/2009

Drug/Important Bio-Agent (IBA)

1Antiviral Agents (Antivirals)IBA
01/2021
1sisunatovirIBA
01/2021
13-pyridinylboronic acidIBA
06/2015
12-chloroquinolineIBA
06/2015
1MAP-kinase-activated kinase 2IBA
06/2015
1AcidsIBA
06/2015
1BromidesIBA
06/2015
1Class I Phosphatidylinositol 3-KinasesIBA
11/2011
1Phosphotransferases (Kinase)IBA
11/2011
1TOR Serine-Threonine KinasesIBA
11/2011
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
02/2010
1MTOR InhibitorsIBA
02/2010
1PI 620IBA
07/2009
1PI 540IBA
07/2009
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
07/2009
1PI103IBA
07/2009
1Protein Isoforms (Isoforms)IBA
07/2009
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2004
1Multidrug Resistance-Associated ProteinsIBA
03/2004